Literature DB >> 16487238

The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis.

A H Montes1, Victor Asensi, Victoria Alvarez, Eulalia Valle, M G Ocaña, A Meana, J A Carton, Jose Paz, J Fierer, A Celada.   

Abstract

Osteomyelitis is a bone infection caused mostly by Staphylococcus aureus but also by Gram-negative bacteria. Toll-like receptors (TLRs), after recognizing microbial products, induce a signal in neutrophils, leading to NF-kappaB activation and transcription of pro-inflammatory genes. Polymorphisms in TLR2 (Arg753Gln) and TLR4 (Asp299Gly, Thr399Ile) genes are associated with bacterial infections, we therefore studied these polymorphisms in osteomyelitis patients. Homozygotes for the TLR4 (Asp299Gly) polymorphism were significantly more frequent among the 80 osteomyelitis patients than in the 155 healthy controls (3/80, 3.8%versus 0/155, 0%; P = 0.038). Carriers of one or two G alleles of this tlr4 polymorphism were more likely to have Gram-negative, haematogenous and/or chronic osteomyelitis than those without this mutation (P < 0.031). Patients with the TLR4 (Thr399Ile) mutant, which cosegregates with the TLR4 (Asp299Gly), were also carriers of this second polymorphism. No differences for the TLR2 (Arg753Gln) genotypes were found between patients and controls. Neutrophils of patients homozygous for the TLR4 (Asp299Gly) polymorphism showed lower LPS-induced apoptosis reduction, phosphorylation of the inhibitor of NF-kappaB, and lower IL-6 and TNF-alpha levels (P < 0.05). We report here for the first time an association between this TLR4 polymorphism and susceptibility to Gram-negative bacteria and haematogenous osteomyelitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487238      PMCID: PMC1809620          DOI: 10.1111/j.1365-2249.2005.03002.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Determination of the TLR4 genotype using allele-specific PCR.

Authors:  E Lorenz; K L Frees; D A Schwartz
Journal:  Biotechniques       Date:  2001-07       Impact factor: 1.993

2.  The cytokine synthesis by heterozygous carriers of the Toll-like receptor 4 Asp299Gly polymorphism does not differ from that of wild type homozygotes.

Authors:  Michael Heesen; Brunhilde Bloemeke; Dagmar Kunz
Journal:  Eur Cytokine Netw       Date:  2003 Oct-Dec       Impact factor: 2.737

3.  Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease.

Authors:  M Folwaczny; J Glas; H-P Török; O Limbersky; C Folwaczny
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

4.  Bacterial lipoprotein delays apoptosis in human neutrophils through inhibition of caspase-3 activity: regulatory roles for CD14 and TLR-2.

Authors:  Colm P Power; Jiang H Wang; Brian Manning; Malcolm R Kell; Noel J Aherne; Noel F Aherne; Qiong D Wu; H Paul Redmond
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

5.  Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria.

Authors:  J Baran; K Guzik; W Hryniewicz; M Ernst; H D Flad; J Pryjma
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

6.  Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock.

Authors:  Eva Lorenz; Jean Paul Mira; Kathy L Frees; David A Schwartz
Journal:  Arch Intern Med       Date:  2002-05-13

7.  A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease.

Authors:  R C Read; J Pullin; S Gregory; R Borrow; E B Kaczmarski; F S di Giovine; S K Dower; C Cannings; A G Wilson
Journal:  J Infect Dis       Date:  2001-07-30       Impact factor: 5.226

8.  Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome.

Authors:  M F Jimenez; R W Watson; J Parodo; D Evans; D Foster; M Steinberg; O D Rotstein; J C Marshall
Journal:  Arch Surg       Date:  1997-12

9.  Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection.

Authors:  L Hou; H Sasaki; P Stashenko
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

10.  A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection.

Authors:  E Lorenz; J P Mira; K L Cornish; N C Arbour; D A Schwartz
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

View more
  31 in total

1.  IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).

Authors:  Zhihong Chen; Lingkai Su; Qingan Xu; Jenny Katz; Suzanne M Michalek; Mingwen Fan; Xu Feng; Ping Zhang
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

2.  Alveolar bone loss in relation to toll-like receptor 4 and 9 genotypes and Porphyromonas gingivalis carriage.

Authors:  U K Gursoy; Q He; P Pussinen; S Huumonen; E Könönen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-04       Impact factor: 3.267

3.  Genetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasis.

Authors:  Theo S Plantinga; Omar J M Hamza; Janet A Willment; Bart Ferwerda; Nicole M D van de Geer; Paul E Verweij; Mecky I N Matee; Kathy Banahan; Luke A J O'neill; Bart-Jan Kullberg; Gordon D Brown; André J A M van der Ven; Mihai G Netea
Journal:  J Acquir Immune Defic Syndr       Date:  2010-09       Impact factor: 3.731

4.  TLR4, IL10RA, and NOD2 mutation in paediatric Crohn's disease patients: an association with Mycobacterium avium subspecies paratuberculosis and TLR4 and IL10RA expression.

Authors:  Josef Wagner; Narelle A Skinner; Anthony G Catto-Smith; Donald J S Cameron; Wojtek P Michalski; Kumar Visvanathan; Carl D Kirkwood
Journal:  Med Microbiol Immunol       Date:  2013-03-02       Impact factor: 3.402

5.  Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background.

Authors:  Andre Bleich; John P Sundberg; Anna Smoczek; Reinhard von Wasielewski; Maike F de Buhr; Lydia M Janus; Gwen Julga; Sya N Ukena; Hans-J Hedrich; Florian Gunzer
Journal:  Int J Exp Pathol       Date:  2007-11-13       Impact factor: 1.925

Review 6.  Functional consequences of toll-like receptor 4 polymorphisms.

Authors:  Bart Ferwerda; Matthew Bb McCall; Karlijn Verheijen; Bart-Jan Kullberg; André Jam van der Ven; Jos Wm Van der Meer; Mihai G Netea
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

7.  Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study.

Authors:  Sherene Shalhub; Christopher E Junker; Scott D Imahara; Michael N Mindrinos; Sharmila Dissanaike; Grant E O'Keefe
Journal:  J Trauma       Date:  2009-01

Review 8.  Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer.

Authors:  A Trejo-de la O; P Hernández-Sancén; C Maldonado-Bernal
Journal:  Genes Immun       Date:  2014-03-13       Impact factor: 2.676

9.  Lipopolysaccharide-induced bone resorption is increased in TNF type 2 receptor-deficient mice in vivo.

Authors:  Anower Hussain Mian; Hiroaki Saito; Neil Alles; Hitoyata Shimokawa; Kazuhiro Aoki; Keiichi Ohya
Journal:  J Bone Miner Metab       Date:  2008-08-30       Impact factor: 2.626

10.  Toll-like receptors 2 and 4 and their mutations in patients with otitis media and middle ear effusion.

Authors:  Young Chan Lee; Chul Kim; Ju Sup Shim; Jae Yong Byun; Mun Suh Park; Chang Il Cha; Young Il Kim; Jin Woo Lee; Seung Geun Yeo
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-12-26       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.